Skip navigation

Evaluate the Impact of Shifting Reimbursement Models on Patient Access, Outcomes and Overall Oncology Costs

October 3-4, 2019
  • Scottsdale, AZ

The 14th Annual Value Based Oncology Management is the forum to hear the latest perspectives on critical issues impacting oncology care management. This highly acclaimed annual forum convenes payers, providers, PBMs, manufacturers and specialty pharmacies to examine current trends, challenges and best practices to control costs, reduce variation in care and improve patient outcomes. Specifically, you will hear leading thought leaders discuss:

In-Depth Discussions, Panel Sessions and Case Presentations Will Address:

  • The potential impact of the significant increase in risk-based models with payors by 2020 on patient access, outcomes and costs
  • How to navigate the changes in reimbursement models
  • The evolution of biosimilars impact on total cost of care
  • Metrics to determine the therapeutic effectiveness of oncology treatments and how to evaluate outcomes as new therapies evolve at such a rapid pace
  • The integration of claims and EHR data to stratify oncology patients and drive better treatment decisions
  • A greater emphasis on palliative care and its impact on oncology overall costs
  • How increased collaboration across the oncology care continuum can impact access, costs and outcomes
  • The future of precision oncology

Download the Conference Preview

14th Annual Value-Based Oncology Management Summit

Evaluate the Impact of Shifting Reimbursement Models on Patient Access, Outcomes and Overall Oncology Costs

The 14th Annual Value Based Oncology Management is the forum to hear the latest perspectives on critical issues impacting oncology care management. This highly acclaimed annual forum convenes payers, providers, PBMs, manufacturers and specialty pharmacies to examine current trends, challenges and best practices to control costs, reduce variation in care and improve patient outcomes. Specifically, you will hear leading thought leaders discuss:

In-Depth Discussions, Panel Sessions and Case Presentations Will Address:

  • The potential impact of the significant increase in risk-based models with payors by 2020 on patient access, outcomes and costs
  • How to navigate the changes in reimbursement models
  • The evolution of biosimilars impact on total cost of care
  • Metrics to determine the therapeutic effectiveness of oncology treatments and how to evaluate outcomes as new therapies evolve at such a rapid pace
  • The integration of claims and EHR data to stratify oncology patients and drive better treatment decisions
  • A greater emphasis on palliative care and its impact on oncology overall costs
  • How increased collaboration across the oncology care continuum can impact access, costs and outcomes
  • The future of precision oncology

Download the Conference Preview